Pirazinamida (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pirazinamida" in Catalan language version.

refsWebsite

Global rank Catalan rank

7nih.gov

4^th place

7^th place

5doi.org

2^nd place

6^th place

2web.archive.org

1^st place

1pdiconnect.com

low place

1asnjournals.org

low place

1atsjournals.org

low place

asnjournals.org

jasn.asnjournals.org

Ichida K, Hosoyamada M, Hisatome I, Enomoto A, Hikita M, Endou H, Hosoya T «Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion». J. Am. Soc. Nephrol., 15, 1, 1-2004, pàg. 164–73. DOI: 10.1097/01.ASN.0000105320.04395.D0. PMID: 14694169.

atsjournals.org

ajrccm.atsjournals.org

Yee D et al. «Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis». Am J Resp Crit Care Med, 167, 11, 2003, pàg. 1472–7. Arxivat de l'original el 2006-02-12. DOI: 10.1164/rccm.200206-626OC. PMID: 12569078 [Consulta: 2 agost 2015].

doi.org

dx.doi.org

Hong Kong Chest Service, Medical Research Council «Controlled trial of four thrice weekly regimens and a daily regimen given for 6 months for pulmonary tuberculosis». Lancet, 1, 8213, 1981, pàg. 171–4. DOI: 10.1016/S0140-6736(02)95623-0. PMID: 6109855.
Ichida K, Hosoyamada M, Hisatome I, Enomoto A, Hikita M, Endou H, Hosoya T «Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion». J. Am. Soc. Nephrol., 15, 1, 1-2004, pàg. 164–73. DOI: 10.1097/01.ASN.0000105320.04395.D0. PMID: 14694169.
East and Central African/Medical Research Council Fifth Collaborative Study «Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 9-month) for pulmonary tuberculosis». Tubercle, 64, 3, 1983, pàg. 153–166. DOI: 10.1016/0041-3879(83)90011-9. PMID: 6356538.
British Thoracic Society «A controlled trial of 6 months chemotherapy in pulmonary tuberculosis, final report: results during the 36 months after the end of chemotherapy and beyond». Br J Dis Chest, 78, 4, 1984, pàg. 330–336. DOI: 10.1016/0007-0971(84)90165-7. PMID: 6386028.
Yee D et al. «Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis». Am J Resp Crit Care Med, 167, 11, 2003, pàg. 1472–7. Arxivat de l'original el 2006-02-12. DOI: 10.1164/rccm.200206-626OC. PMID: 12569078 [Consulta: 2 agost 2015].

nih.gov

ncbi.nlm.nih.gov

Hong Kong Chest Service, Medical Research Council «Controlled trial of four thrice weekly regimens and a daily regimen given for 6 months for pulmonary tuberculosis». Lancet, 1, 8213, 1981, pàg. 171–4. DOI: 10.1016/S0140-6736(02)95623-0. PMID: 6109855.
Centers for Disease Control and Prevention «Targeted tuberculin testing and treatment of latent tuberculosis infection». MMWR, 49, RR–6, 2000, pàg. 31–32. PMID: 10881762.
Spaia S, Magoula I, Tsapas G, Vayonas G «Effect of pyrazinamide and probenecid on peritoneal urate transport kinetics during continuous ambulatory peritoneal dialysis». Perit Dial Int, 20, 1, 2000, pàg. 47–52. Arxivat de l'original el 2019-12-09. PMID: 10716583 [Consulta: 2 agost 2015].
Ichida K, Hosoyamada M, Hisatome I, Enomoto A, Hikita M, Endou H, Hosoya T «Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion». J. Am. Soc. Nephrol., 15, 1, 1-2004, pàg. 164–73. DOI: 10.1097/01.ASN.0000105320.04395.D0. PMID: 14694169.
East and Central African/Medical Research Council Fifth Collaborative Study «Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 9-month) for pulmonary tuberculosis». Tubercle, 64, 3, 1983, pàg. 153–166. DOI: 10.1016/0041-3879(83)90011-9. PMID: 6356538.
British Thoracic Society «A controlled trial of 6 months chemotherapy in pulmonary tuberculosis, final report: results during the 36 months after the end of chemotherapy and beyond». Br J Dis Chest, 78, 4, 1984, pàg. 330–336. DOI: 10.1016/0007-0971(84)90165-7. PMID: 6386028.
Yee D et al. «Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis». Am J Resp Crit Care Med, 167, 11, 2003, pàg. 1472–7. Arxivat de l'original el 2006-02-12. DOI: 10.1164/rccm.200206-626OC. PMID: 12569078 [Consulta: 2 agost 2015].

pdiconnect.com

Spaia S, Magoula I, Tsapas G, Vayonas G «Effect of pyrazinamide and probenecid on peritoneal urate transport kinetics during continuous ambulatory peritoneal dialysis». Perit Dial Int, 20, 1, 2000, pàg. 47–52. Arxivat de l'original el 2019-12-09. PMID: 10716583 [Consulta: 2 agost 2015].

web.archive.org

Spaia S, Magoula I, Tsapas G, Vayonas G «Effect of pyrazinamide and probenecid on peritoneal urate transport kinetics during continuous ambulatory peritoneal dialysis». Perit Dial Int, 20, 1, 2000, pàg. 47–52. Arxivat de l'original el 2019-12-09. PMID: 10716583 [Consulta: 2 agost 2015].
Yee D et al. «Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis». Am J Resp Crit Care Med, 167, 11, 2003, pàg. 1472–7. Arxivat de l'original el 2006-02-12. DOI: 10.1164/rccm.200206-626OC. PMID: 12569078 [Consulta: 2 agost 2015].